background image

Paid Clinical Trials Bismarck

Discover 63 paid clinical trials in Bismarck, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

for
Recurrent Endometrial Carcinoma,
Location: Bismarck ND, Fargo ND, Sioux Falls SD, Deer River MN,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05554328

Phase2, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Bismarck ND, Pierre SD, Saint Paul MN, Cheyenne WY,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
New

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Bismarck ND, Fargo ND, Rapid City SD,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase3, Recruiting

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

for
Rectal Cancer
Location: Bismarck ND, Fargo ND, Winnipeg, Bemidji MN,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06205485

Phase3, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Bismarck ND, Fargo ND, Grand Forks ND, Winnipeg,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT05721755

Phase3, Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

for
Peritoneal Malignant Mesothelioma
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05001880

Phase2, Recruiting

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

for
Locally Advanced Malignant Solid Neoplasm,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05554380

Phase2, Recruiting

Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons

for
PTSD - Post Traumatic Stress Disorder,
Location: Bismarck ND, Osceola AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT06923423

Recruiting